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Resorcinol on treatment with ethyl acetoacetate
(EAA) in the presence of cone. H2S04 gives 7-hy-
droxy-4-methylcoumarin 1 which reacts with aromatic
acid hydrazides affording l-arylamido-7-hydroxy-2-
oxo-4-methylquinolines (carbostyrils) 2. Interaction of
2 with aromatic amines in the presence of anhydrous
ZnCl2 results in the formation of J-arylamido-
7-arylamino-2-oxo-4-methylquinolines 3. Compounds
3 undergo cyclisation with sulphur and iodine giving
l-arylamido- 2-oxo-4-methylpyrido[ b]phenothiazines 4.
The CNS activity of 4 has been reported.
Phenothiazine derivatives constitute an import-
ant class of compounds possessing diverse types
of biological properties including antiparkinsoni-
an, anticonvulsant and antihistarninic activities 1-7.
Further, several pyridolbjphenothiazines have
been reported to possess antiviral and antiparasi-
tic properties=". In continuation of our on-going
research programme on newer phenothiazine der-
ivatives of biological significance, it was consid-
ered of interest to synthesize some 1-arylamido- 2-
oxo-4-methylpyrido[ bjphenothiazines and evaluate
their CNS activity.
l-Arylamido- 2-oxo-4-methylpyrido[ bjphenothia-
zines 4 were prepared by heating a mixture of l-aryl-
amido- 7-arylamino- 2-oxo-4-methylquinolines 3 (cf.
Table I) powdered sulphur and iodine (cf. Scheme I) at
215-220°C in an oil-bath. THe synthesized com-
pounds wre characterized with the help of elemental
analysis, IR and 1H NMR spectral data. IR spectra of
the above compounds showed absorption bands at
3400 ± 10 em - 1 due to secondary amino group
and 16S0 em - 1 due to carbonyl of amide. The 1H
NMR spectra of compounds 4a-c (Table I)
showed signals at 66.5-S.0 for aromatic protons,
two singlets at 2.50 and 2.54 due to C-CH3 pro-
tons at position-4 and Ar--CH3 protons, respect-
ively.yThe singlet at 03.14 was due to Ar-OCH3
protons. The broad singlet at 6S.7-11.2 was due
to NH protons. Methine protons at position-S in


















Pharmacological activity. Compounds 4 were
screened to ascertain various pharmacological ef-
fects in relation to CNS in albino mice of either
sex weighing 15-25 g each. The method of Weil'"
was followed for the determination of approxim-
ate lethal dose (ALDso)' The .compounds were
found to be both CNS stimulants as well as de-
pressants in nature. Compounds 4b and 4c exhi-
bited stimulant activity while compounds 4a and
4b showed tremorigenic effect (cf.Table II). In ad-
dition, compounds 4a and 4d were found to be
depressants in nature. Except compound 4a, all
other compounds were found without any writh-
ing effect (Table II).
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Compd R R' N(%)
Found Calcd.
3a C6HS 7-CH3 170-72 52 C24H21NP2 10.94 10.96
3b C6HS 9-CH3 146 54 C24H21N302 10.95 10.96
3c C6HS 7-0CH3 162 51 C24H21N303 10.50 10.52
3d C6HsCH = CH 7-CH3 179-80 53 C26H23NP2 10.24 10.26
3e C6HsCH = CH 9-CH3 166 52 C26H23N302 10.23 10.26
3f C6HsCH=CH 7-0CH3 181 53 C26H23N303 9.86 9.88
4a· C6HS 7-CH3 230 47 C24H19NP2S 10.14 10.16
4b· C6HS 9-CH3 240 45 C24H19NP2S 10.13 10.16
4c· C6HS 7-0CH3 80-81 44 C24H19NP3S 9.77 9.79
4d C6HsCH = CH 7-CH3 195-98 43 C26H21NP2S 9.53 9.56
4e C6HsCH=CH 9-CH3 208-9 42 C26H21NP2S 9.54 9.56
4f C6HsCH=CH 7-0CH3 174-75 46 C26H21NP3S 9.20 9.23
Compounds 4 showed IR (KBr) absorption bands at 3400 ± 10 (NH), 1.680 (C = 0), 3300 (Aromatic C-H) and 1620 ± 10
em - 1(N - H bending).
*lH NMR (CDCI3 + DMSO-d6) : M.5-8.0 (m, lOH, Ar-H), 2.50(s, 3H, CH3 at position-a), 2.54 (s, 3-H, Ar-CH3)' 3.14 (s, 3H,
Ar.-OCH3)' 8.7 (br s, 1H, NH) and 11.2 (br, s, 1H, NHCOR, DzO exchangeable).
-
Table II-CNS activity data of 1-Arylarnido-2-oxo-4-methylpyrido[ b]phenothiazines 4
Compd R R' Dose Gross Central Nervous System Activity
(mglkg) Mortality Body temp. SMA Other gross Al.Dso
i.p. (0e) effects (mg/kg)
4a C6HS 7-CH3 464 0/4 Writhing ( + ) 316
Ataxia ( +)
Tremor ( +)
215 0/4 React ~
63.2 0/5
4b C6HS 9-CH3 464 0/4 Reactt 681
Reactt
1000 4/4 Tremor ( +)
136.2 0/5 B.2 t
4c 02Hs 7-0CH3 464 0/4 t Resp. t 681




136 0/5 to.1 tt React t
Resp. t
4d C6Hs-CH=CH 7-CH3 464 4/4 Resp. ~ 100
React. ~
215 4/4 Resp. ~
React. ~
100 2/4 React. ~
46.4 0/4 React. ~
20 0/5 No effect
4e C6HsCH=CH 9-CH3 464 4/4. Resp. t 316
React. t
215 0/4 Resp. t
React. t
63.2 0/5 Resp. t
React. t
4f C6HsCH=CH 7-0CH3 464 0/4 Resp. t >1000
React. t
1000 0/4 Resp. t
React. t
200 0/5 Resp. t
React. t
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Experimental Section
Melting points were determined in open capilla-
ries using a Toshniwal melting point apparatus
and are uncorrected. IR spectra in KBr were re-
corded on a Perkin-Elmer 157 spectrophotometer
(vmax in em - 1) and 1H NMR spectra in a mixture
of DMSO-~ and CDCl3 on a Varian 1\oD instru-
ment using TMS as internal standard (chemical
shift in b, ppm),
4-Methyl-7-hydroxycoumarin 1. The method
of Pechmann and Duisberg" was followed for the
preparation of 4"methyl- 7-hydroxy coumarin.
Aromatic acid hydtazides. Aromatic acid hy-
drazides required in the present synthesis were
prepared following the method of Vogel".
l-Arylamido-7 -hydroxy- 2- oxo-4-methylquino-
lines 213. A mixture of 4-methyl-7-hydroxycou-
marin 1 (0.1 mole) and an appropriate aromatic
acid hydrazide (0.1 mole) in anhydrous pyridine
(100 mL) was refluxed for 6 hr on a sand-bath
under anhydrous conditions. The reaction mixture
was allowed to stand at room temperature for 1
hr and poured into ice-cold water containing
cone. HCL (10 mL). The solid which separated
out, was allowed to settle. It was filtered and
washed repeatedly with water, dried in a vacuum
desiccator and crystallized from ethanol. Follow-
ing compounds were prepared:
I-Benzamido-7 - hydroxy- 2-oxo-4-methylquino-
line (2; R = C6HS): m.p. 160-162°, yield 60%
(Found: N, 9.49. C17H14N203 requires N 9.52%).
I-Styrylamido-7 -hydroxy- 2-oxo-4-methylquino-
line (2: R=C6Hs-CH=CH-): m.p. 170-72°,
yield 60% (Found: N, 8.71. C19H16N203 requires
N8.75%).
l-Arylamido-7 -arylamino- 2-oxo-4-methylquino-
lines 314. A mixture of 1-arylamido-7-hydroxy-2-
oxo-4-methylquinoline (2; 0.05 mole) and an aro-
matic primary amine (0.05 mole) in absolute etha-
nol (50 mL) was heated under reflux in the pres-
ence of anhydrous ZnCl2 (0.5 gm) for 5 hr on a
steam-bath. The contents were cooled when a
crude solid mass separated out which was washed
repeatedly with acidified water to remove inor-
ganic materials. It was filtered, dried and crystal-
lised from ethanol. The compounds thus, synthe-
sised, are recorded in Table 1.
l-Arylamido- 2-oxo-4-methylpyrido( /JIphenothi-
azines 414. A mixture of 3 (0.G1 mole), sulphur
(0.1 mole) and iodine (0.5 g) was rapidly heated
at 215-220°C in an oil-bath and maintained at
this temperature for 1 hr. The hot melt was rapid-
ly poured into a mortor and crushed to a fine
powder. It was washed with water, dried and crys-
tallised from ethanol containing animal charcoal.
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